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Interleukin-7 (IL-7) is an essential cytokine for T cells. 
However, IL-7 is not produced by T cells themselves such 
that T cells are dependent on extrinsic IL-7. In fact, in the ab-
sence of IL-7, T cell development in the thymus as well as 
survival of naive T cells in the periphery is severely impaired. 
Furthermore, modulating IL-7 availability in vivo either by ge-
netic means or other experimental approaches determines 
the size, composition and function of the T cell pool. 
Consequently, understanding IL-7 expression is critical for 
understanding T cell immunity. Until most recently, however, 
the spatiotemporal expression of in vivo IL-7 has remained 
obscured. Shortage of such information was partly due to 
scarce expression of IL-7 itself but mainly due to the lack of 
adequate reagents to monitor IL-7 expression in vivo. This 
situation dramatically changed with a recent rush of four in-
dependent studies that describe the generation and charac-
terization of IL-7 reporter mice, all utilizing bacterial artificial 
chromosome transgene technology. The emerging consensus 
of these studies confirmed thymic stromal cells as the major 
producers of IL-7 but also identified IL-7 reporter activities in 
various peripheral tissues including skin, intestine and lymph 
nodes. Strikingly, developmental and environmental cues ac-
tively modulated IL-7 reporter activities in vivo suggesting 
that IL-7 regulation might be a new mechanism of shaping T 
cell development and homeostasis. Collectively, the avail-
ability of these new tools opens up new venues to assess un-
answered questions in IL-7 biology in T cells and beyond.
[Immune Network 2011;11(1):1-10]
INTRODUCTION
Originally described as a pre-B cell growth factor expressed 
i n  b o n e  m a r r o w  s t r o m a l  c e l l s  ( 1 ) ,  interleukin-7  (IL-7)  was 
subsequently identified as an essential and non-redundant cy-
tokine  in  T  cells  (2,3).  In  fact,  IL-7  plays  a  critical  role  in 
every aspect of T cell biology, including early T cell develop-
ment in the thymus, CD4/CD8 lineage choice during positive 
selection as well as maintaining the survival and homeostasis 
of naïve and memory T cells in the periphery (2-6). Genetic 
deficiencies in IL-7 or in any component of the IL-7 receptor 
(IL-7R) complex, namely the IL-7R alpha (IL-7Rα) chain and 
the cytokine receptor shared common gamma (γc)-chain, re-
sult  in  severely  impaired  thymopoiesis  and  T  cell  survival. 
IL-7 deficiency is manifested in humans as T(−)B(＋)NK(−) 
SCID (severe combined immunodeficiency) (7,8) and in mice 
as severe deficiency in both B and T cells (2,3,9). The re-
quirement of IL-7 in T cell development and survival is chiefly 
due to its anti-apoptotic effects by upregulating expression of 
Bcl-2 and Mcl-1 (10,11), but also because of its trophic ef-
fects,  such  as  inducing  expression  of  glucose  transporter-1 
(12). In mature naïve T cells, IL-7 is a non-redundant survival 
cytokine that cannot be replaced by other pro-survival cyto-
kines (4,5,13,14). This non-redundancy is also partly the case 
for  memory  T  cell  maintenance  (15).  Interestingly,  antigen 
specific memory CD8 T cells are still largely dependent on 
IL-7  for  cell  survival  but  intermittent  and  basal  homeostatic 
proliferation of these cells seems to be more dependent on 
IL-15 (4,16-18). This is in contrast to the bulk of memory phe-Detecting In Vivo Interleukin-7
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notype  CD8  T cells  which are  dependent  on  IL-15  but not 
IL-7 (19). The molecular basis for such different cytokine re-
quirements  is  unclear.  Nevertheless,  it  remains  evident  that 
IL-7  is  a  key  molecule  for  maintaining  the  fitness  and  size 
of the peripheral T cell pool by providing essential survival 
signals.
    IL-7  signaling  is  transduced  by  the  IL-7R  heterodimer, 
which is composed of the IL-7-specific IL-7R α-chain and the 
γc-chain, which is a shared component with other members 
of the γc-cytokine family, i.e. IL-2, IL-4, IL-7, IL-9, IL-15 and 
IL-21 (20). Ligand-induced heterodimerization of the IL-7Rα/ 
γc-chains leads to juxtaposition and trans-phosphorylation of 
receptor-associated  tyrosine  kinases  JAK1  and  JAK3  (21). 
Activated JAKs then phosphorylate specific tyrosine residues 
i n  t h e  I L - 7 R α cytosolic  domain  that  attract  STAT5  (Signal 
Transducers and Activators of Transcription 5) and PI-3 kin-
ases  for  JAK-mediated  phosphorylation  and  further  down-
stream signaling. Known downstream molecules of IL-7 sig-
n a l i n g  i n c l u d e  a m o n g  o t h e r s  B c l - 2 ,  B c l - X L ,  M c l - 1 ,  G l u t - 1 ,  
Cdc25A, IL-7Rα, Runx3, and CD8 coreceptors, which are all 
essential  for  functional  fitness  and  survival  of  T  cells 
(6,10,12,22-25).
    Notably, multiple studies have documented that IL-7 func-
tions beyond serving as a pro-survival factor. For example, 
IL-7 provides specific differentiation signals in immature lym-
phocytes  by  opening  up  the  TCRγ-chain  and  the  im-
munoglobulin  heavy  chain  locus  for  antigen  receptor  re-
combination  (26,27).  In  this  line,  we  recently  showed  that 
IL-7 is necessary to specify CD8 lineage differentiation during 
CD4/CD8  cell  fate  choice  in  the  thymus  by  inducing  ex-
pression  of  the  transcription  factor  Runx3  (6).  Additionally, 
IL-7 is involved in the development of secondary lymphoid 
tissues  since  impaired  IL-7  signaling  results  in  defects  in 
lymph node organogenesis (28). Here, IL-7 seems to regulate 
the size of the fetal lymphoid tissue inducer (LTi) cell pool 
that interacts with stromal organizer cells to form lymphoid 
tissues  (29).  Thus,  IL-7  is  a  critical  player  in  cell  lineage 
choice and differentiation during lymphocyte as well as lym-
phoid tissue development. Furthermore, IL-7 also controls ho-
meostasis of several innate lymphoid cell subsets (30). Within 
the  T  cell  compartment,  IL-7  controls  the  TCR  activation 
threshold of naïve CD8 T cells by tuning CD8 coreceptor ex-
pression levels to the self-specificity of the TCR. In this way, 
IL-7 maintains a self-reactive but not autoimmune T cell pool 
(31).  Finally,  IL-7  downregulates  expression  of  its  own 
receptor. IL-7 signaled cells express lower surface levels of 
IL-7R so that unsignaled cells outcompete IL-7 signaled T cells 
for remaining IL-7. We previously showed that maintaining 
this negative feedback loop is necessary for maximizing the 
size of the naïve T cell pool (32). Collectively, IL-7 is a mul-
ti-faceted pro-survival cytokine that governs the development, 
differentiation, and maintenance of T cells in a non-redundant 
manner.
    Despite  playing  such  critical  roles,  however,  there  is  re-
markably little known about IL-7 expression and regulation 
in  vivo.  In  fact,  the  identity  of  IL-7  producing  cells  in  the 
thymus is not fully understood as well as the precise location 
of  IL-7  expression  in  peripheral  tissues  remains  veiled. 
Recently, much light was shed on the in vivo source and reg-
ulation  of  IL-7  expression  by  a  series  of  four  independent 
publications reporting the generation and characterization of 
IL-7  reporter  mice.  Using  fluorescent  proteins,  Cre  re-
combinase and other reporter proteins, IL-7 transcriptional ac-
tivities  were  monitored  in  vivo  and  so  depicted  a  spatio-
temporal expression profile of IL-7 expression during ontog-
eny  and  steady  state  conditions.  Here  we  review  the  ex-
perimental results and their findings in context of IL-7 medi-
ated  T  cell  development  and  peripheral  homeostasis.
OUTSTANDING QUESTIONS ON IL-7 EXPRESSION
Constant IL-7 signaling is critical for mature T cells. Adoptive 
transfer  of  naïv e  T  c e l l s  i n t o  a n  I L - 7  d e f i c i e n t  e n v i r o n m e n t  
fail to induce homeostatic proliferation and transferred cells 
succumb to programmed cell death (4,5). Even as all T line-
age cells are critically dependent on IL-7, no lymphocytes in-
cluding T cells themselves produce IL-7 (33). Thus, T cells 
are dependent on exogenous IL-7 (4,5). Importantly, the ana-
tomical locations where immature thymocytes and T cells en-
counter  IL-7  for  development  and  homeostasis  are  not  en-
tirely  mapped.  The  cellular  sources  of  IL-7  in  these  tissues 
are also still disputed. Previously, IL-7 message and proteins 
have been reported in various tissues including the thymus 
and secondary lymphoid organs such as spleen (34,35) and 
lymph  nodes  (36).  Also,  other  tissues  were  implicated  as 
sources of in vivo IL-7 which comprise the intestine (37), hu-
man  liver  (38),  skin  (39,40),  murine  ovaries  (41),  human 
brain (42), and human prostate (43). But the precise identities 
of  IL-7  expressing  cells  remain  still  obscure.
    While IL-7 is generally considered as a secreted cytokine, 
its expression levels in serum are extremely low suggesting 
that IL-7 in vivo is limiting and that IL-7 would be consumed Detecting In Vivo Interleukin-7
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locally. In fact, serum IL-7 was never convincingly detected 
in mice sera until most recently, when Mackall and colleagues 
were able to determine serum IL-7 in wild type mice at levels 
of 10 pg/ml (44). Scarce IL-7 in the circulation on the one 
hand suggests that IL-7 would be produced only at very low 
levels, but on the other hand there is also the possibility that 
IL-7 is sequestered from serum by being complexed to the 
extracellular matrix (ECM). Potentially, such immobilized IL-7 
could be the actual bioactive form of IL-7  in vivo. Indeed, 
MHC  class  II
＋  thymic  epithelial  cells  do  express  the  ECM 
components fibronectin and heparin sulfate, and IL-7 signal-
ing in immature thymocytes is likely mediated by an ECM-as-
sociated form of IL-7 (45). Moreover, IL-7 can also act as a 
heterodimer when bound to a variant β-chain of the hep-
atocyte  growth  factor  (HGF),  which  is  then  known  as  the 
pre-pro-B cell growth-stimulating factor (PPBSF). Both heter-
odimerization of IL-7 and HGFβ and the biological activity 
of PPBSF are dependent on low levels of heparin sulfate-de-
rived  oligosaccharides.  HGF  is  a  cytokine  homologous  to 
plasminogen,  and  these  data  suggest  that  HGF  β-chains 
could allow interaction of IL-7 with the stromal cell surface 
and thus deliver IL-7 signaling as a membrane bound cyto-
kine (46). If this is indeed the case, then identifying the actual 
IL-7  producer  cells  in  vivo  would  be  even  more  critical  to 
understand where and when IL-7 signaling is happening in 
T  cells.
    Without identifying IL-7 producers, however, it is difficult 
to understand whether and how IL-7 expression is controlled. 
Generally, IL-7 production in vivo is considered to be con-
stitutive and unaffected by external signals, so that IL-7 avail-
ability is a limiting factor in determining the size of the pe-
ripheral T cell pool (47). On the other hand, there is a great 
body  of  evidence  that  IL-7  expression  in  vivo c a n  b e  
modulated. Serum IL-7 concentration is elevated in lympho-
penic humans and other primates (48,49), and in the mouse, 
a  novel  IL-7R  mediated  IL-7  expression  feedback  loop  was 
recently reported, further indicating that IL-7 production is ac-
tively regulated in vivo (44). Furthermore, IL-6 and TLR sig-
naling in the liver have been shown to induce IL-7 expression 
i n  h e p a t o c y t e s  s u g g e s t i n g  t h a t  e x p r e s s i o n  o f  i m m u n o r -
egulatory  IL-7  is  broader  and  more  dynamically  regulated 
than  currently  presumed  (50).  Because  of  the  lack  of  ad-
equate reagents, however, the whole scope of IL-7 expression 
remained  largely  unaddressed.
GENERATION AND CHARACTERIZATION OF IL7 
REPORTER MICE
Recently, four independent studies reported a total of five dif-
ferent IL-7 reporter mice whose detailed characterizations will 
be discussed below (51-54). All IL-7 reporter mice were gen-
erated by basically the same strategy employing BAC trans-
genesis and insertion of a reporter gene into the IL-7 locus. 
Individual  cloning  schematics are summarized  in Fig.  1.  In 
brief, IL-7 BAC transgenes were generated by insertion of a 
reporter gene immediately after the ATG start codon of IL-7 
in exon 1, which effectively disrupts the BAC-encoded IL-7 
gene (Fig. 1). Consequently, all IL-7 reporter BAC transgenes 
do  not  overexpress  IL-7.  The  choices  of  the  IL-7  reporter 
genes, however, were distinct between each study explaining 
possible  variations  among  the  reports  (Table  I).
    The first IL-7 reporter mouse was generated and reported 
by Di Santo and colleagues (51). The BAC reporter construct 
expressed a yellow fluorescence protein (YFP) cDNA down-
stream of the ATG translational start codon of IL-7 exon 1, 
thus  inactivating  the  BAC  IL-7  open  reading  frame.  Conse-
quently, endogenous IL-7 levels are not perturbed and trans-
genic mice did not show any significant differences in the cel-
lular composition of primary and secondary lymphoid organs. 
IL-7  reporter  activities  were  monitored  either  by  flow  cy-
tometry for YFP expression or by immunohistochemistry us-
ing anti-YFP antibodies. Both fetal and adult thymic stromal 
cells were found to contain YFP (IL-7) positive cells which 
were  further  identified  as  CD45
− M H C I I
＋  thymic  epithelial 
c e l l s  ( T E C )  i n  t h e  f e t a l  t h y m u s  a n d  a s  e i t h e r  m e d u l l a r y  o r  
cortical  TEC-specific  markers  bearing  cells  in  the  adult 
thymus. Interestingly, IL-7 reporter activity was not detected 
in either endothelial cells or fibroblasts, suggesting that only 
a subset of specialized TECs produce this cytokine. Of note, 
YFP expression was also not detected in peripheral lymphoid 
organs including the bone marrow, lymph node and spleen. 
This observation, however, does not agree with the general 
idea  of  peripheral  IL-7  being  necessary  for  T  cell  survival 
(4,5).  A  convincing  explanation  for  this  discrepancy,  how-
ever, was provided when quantifying IL-7 mRNA transcripts 
in  gp38
＋  fibroblastic  reticular  cells  in  the  lymph  node  and 
comparing those to the IL-7 mRNA expression in YFP
＋ TECs. 
Fibroblastic reticular cells are an established source of periph-
eral  IL-7  (36),  but  their  IL-7  mRNA  expression  levels  were 
found to be significantly lower than in YFP
＋ TECs. Therefore, 
IL-7 reporter activity in this particular reporter mouse identi-Detecting In Vivo Interleukin-7
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Figure 1. Schematic representation of the BAC constructs for IL-7 reporter mice. Endogenous wildtype IL-7 locus is shown at the top. Alves
et al. (51) generated BAC transgenic mice encoding the yellow fluorescent protein (YFP) under the control of the IL-7 promoter. The YFP gene 
was inserted by homologous recombination downstream of the ATG transcriptional start codon of exon 1 of the IL-7 locus. Repass et al. (52) 
generated two BAC transgenic mice where IL-7 regulatory elements drive either Cre recombinase (IL-7.Cre) or human CD25 (IL-7.hCD25) reporter
expression. Mazzucchelli et al. (53) generated BAC transgenic mice encoding the enhanced cyan fluorescence protein (ECFP) under the control
of the IL-7 promoter (IL7promECFP). The exon 1 sequence, encoding the signal peptide was replaced with the Ecfp cDNA sequence starting
after the ATG start site. Shalapour et al. (54) generated BAC transgenic mice simultaneously expressing enhanced green fluorescent protein (G),
recombinase Cre (C), the human diphtheria toxin receptor (D) and click beetle green luciferase 99 (L) under control of the IL-7 promoter 
(IL-7GCDL). E1∼E5: Exon 1∼Exon 5. UTR: Untranslated region.




BAC clone Source Reporter genes Detection Reference
BAC.IL-7.YFP RP23-446B12 Invitrogen          YFP Direct fluorescence Alves et al., 2009
Anti-YFP antibody
IL-7.hCD25 RPCI-295A3 BACPAC Resources   Human CD25 Anti-hCD25 antibody Repass et al., 2009
 Center, CHORI*
IL7.Cre RPCI-295A3 BACPAC Resources          Cre Crossed to reporter mice Repass et al., 2009
 Center, CHORI*
IL7promECFP RP23-3217 Invitrogen         ECFP Direct fluorescence Mazzucchelli et al., 2009
 Anti-ECFP antibody
IL-7GCDL RP23-446B12 BACPAC Resources         EGFP Shalapour et al., 2010
 Center, CHORI*          Cre Crossed to reporter mouse
    Human DTR Anti-DTR antibody
Click beetle green Bioluminescence
    luciferase 99
*CHORI: Children’s Hospital Oakland Research Institute, YFP: yellow fluorescent protein, hCD25: human CD25, ECFP: enhanced cyan
fluorescent protein, EGFP: enhanced green fluorescent protein, DTR: diphtheria toxin receptor.Detecting In Vivo Interleukin-7
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fies only cells with the highest levels of IL-7 transcription in 
vivo, which is clearly the case for thymic stromal cells as con-
firmed  in  subsequent  studies  by  others.
    Richie and colleagues chose to generate two different IL-7 
reporter transgenes with either the human CD25 or the Cre 
recombinase cDNA inserted into nucleotide position 1 of the 
IL-7  exon  1  (52).  The  constructs  were  designed  to  replace 
the  entire  coding  region  of  IL-7  exon  1  of  the  BAC  clone 
RPCI-295A3  that  contained  the  entire  43  kb  IL-7  locus  and 
its 5’ and 3’ flanking sequences (96 kb of the 5’ sequence 
and 17 kb of the 3’ of the Il7 locus) to include as much of 
the Il7 regulatory elements as possible. IL-7 reporter activities 
were monitored using either anti-human CD25 antibodies in 
IL-7.hCD25  transgenes  or  by  crossing  IL-7.Cre  transgenic 
mice with Rosa26R (55) and R26YFP (56) reporter strains to 
induce  expression  of  either  β-galactosidase  or  YFP,  re-
spectively (52). Reporter gene expression was detected either 
by flow cytometry or in whole mount staining by X-gal and 
by  anti-YFP  antibodies.  In  these  reporter  strains,  IL-7  ex-
pression  faithfully  reproduced  the  results  from  a  previous 
study where in situ hybridization detected IL-7 expression in 
early thymic rudiments as early as at embryonic day 13.5 (57) 
and also in thymic stromal cells. Additionally, IL-7 expression 
was mapped to lymph nodes, bone marrow, liver, small intes-
tine  and  skin.  Importantly,  however,  IL-7  expressing  cells 
were  completely  absent  in  the  spleen.
    Durum and colleagues generated an IL-7 reporter mouse, 
IL7PromECFP, by introducing an enhanced cyan fluorescence 
protein (ECFP) immediately after the translational initiation se-
quence of an IL-7 BAC clone (53). Since direct ECFP fluo-
rescence  was  very  weak  in  these  mice,  the  reporter  signal 
was further enhanced by an anti-ECFP antibody followed by 
fluorescent secondary antibodies. In two-photon microscopy, 
however, ECFP signals were sufficiently strong to perform in-
travital imaging. IL-7 reporter activities were detected in both 
cortex and medulla of the thymus, and further detailed analy-
sis  with  antibodies  for  stromal  cell  subsets  identified  Ly51- 
positive cortical epithelial cells and EpCAM (epithelial cell ad-
hesion molecule) -positive cells, in both the medulla and cor-
tex, as the IL-7 producers. In agreement with the study by 
Alves et al. (51), fibroblasts, endothelial cells and also den-
dritic and myeloid derived cells in the thymus did not show 
IL-7  reporter  expression.  And  as  before,  no  ECFP-positive 
cells were detected in secondary lymphoid tissues and in no 
other additional organs including gut, lung and skin. Similarly 
t o  t h e  Y F P  r e p o r t e r  m i c e  ( 5 1 ) ,  t h e  I L 7 p r o m E C F P  m o u s e  i s  
likely to report IL-7 expression only in IL-7 high expressing 
cells, and accordingly, ECFP-positive cells were found in the 
cervical thymus and also in the bone marrow. Collectively, 
b e c a u s e  o f  t h e  e x t r e m e l y  l o w  l e v e l  o f  I L - 7  t r a n s c r i p t i o n  i n  
peripheral tissues, monitoring reporter activity using IL-7 pro-
moter  dependent  fluorescence  signals  turned  out  to  be  in-
effective outside of the thymus. Rather, linking enzymatic ac-
tivities downstream of IL-7 so that they can either accumulate 
or be enhanced by secondary reporter activity could provide 
greater  sensitivity  in  reporting  IL-7  expression  in  vivo.
    Schuler and colleagues have employed precisely such an 
approach when they established a new IL-7 reporter line (54). 
Here, they subcloned four genes linked to each other as a 
single reporter construct into an IL-7 BAC transgene. The four 
reporter genes were interlinked with P2A peptide sequences 
that  allow  translation  of  polycistronic  mRNA  in  mammalian 
cells (58). This resulted in a transgenic mouse line (IL-7GCDL) 
that  simultaneously  expressed  enhanced  green  fluorescent 
protein (EGFP) (G), Cre recombinase (C), the human diph-
theria toxin receptor (D), and click beetle green luciferase 99 
(L). Again, the reporter construct replaced the IL-7 ATG ini-
tiation  site  so  that  BAC-encoded  IL-7  expression  was 
abolished. Reporter activity was then determined either by in-
jection of luciferin and measuring in vivo bioluminescence or 
by anti-GFP antibodies. Similar to ECFP and YFP reporter ex-
pression (51,53), peripheral lymphoid tissues expressed GFP 
mRNA but failed to exhibit any significant amounts of GFP 
as assessed by flow cytometry or by fluorescence microscopy. 
These results reaffirm that fluorescence proteins are not opti-
mal reagents for detecting the low promoter activity of IL-7 
in vivo. Importantly, in IL-7GCDL mice, even Cre-mediated 
activation of GFP reporter genes was still insufficient to accu-
rately report IL-7 expression when compared to in vivo bio-
luminescence  assays.  Specifically,  while  luciferase  activity 
was  detected  in the thymus, skin,  small intestine, and to a 
lower  level  in  lymph  nodes,  fluorescent  protein  expression 
was  not  detectable  in  any  of  these  organs  except  for  the 
thymus. Notably, even with bioluminescence assays, only low 
or undetectable levels of IL-7 expression were found in the 
heart,  kidney,  liver,  and  spleen  (54).
SPATIOTEMPORAL EXPRESSION OF IL-7 IN VIVO
The  where  and  when  of  IL-7  expression  in  vivo h a s  b e e n  
a hotly contended issue as much as the question of whether 
IL-7  expression  is  actively  regulated  or  constitutively  ex-Detecting In Vivo Interleukin-7
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Table II. Anatomical location of interleukin-7 reporter activity
Study Thymus Bone  marrow Lymph node Spleen Intestine Liver Skin Lung Kidney
Alves et al., 2009 ＋ − − − − − −−−
Repass et al., 2009 ＋ − ＋ − ＋＋ ＋ −−
Mazzucchelli et al., 2009 ＋＋ − − − − −−−
Shalapour et al., 2010 ＋＋ ＋− ＋＋ ＋ ＋ −
pressed (49,59). The current series of IL-7 reporter mice are 
now  providing  insights  into  the  anatomical  distribution  and 
in vivo signals that control IL-7 expression during develop-
ment and homeostasis. This is especially important since, in 
a striking demonstration, Durum and colleagues documented 
that the conventional methods of immunohistochemistry and 
in situ hybridization are quite inadequate to monitor IL-7 ex-
pression in mice (53). Using Cre-recombinase expressing re-
porter mice that mark cells which have expressed and/or are 
currently expressing IL-7, and also using fluorescent proteins 
or luciferase expressing reporter mice that report the actual 
IL-7 expression levels in situ, there is now an emerging con-
sensus  on  IL-7  expression  in  vivo ( T a b l e  I I ) .
    The  thymus,  because  of  IL-7  producing  thymic  stromal 
cells, is likely to be the organ with the highest level of IL-7 
expression.  Specifically,  Alves  et  al.  (51),  describe  a  dis-
tribution  of  IL-7  producing  cells  that  closely  matches  ob-
s e r v a t i o n s  f r o m  Z a m i s c h  e t  a l .  ( 5 7 )  i n  t h a t  I L - 7
＋ c e l l s  a r e  
mostly concentrated around the corticomedullary junction of 
an adult thymus. The phenotypes of IL-7
＋ cells were hetero-
geneous in that they bear markers for both cortical and me-
dullary TECs but they lacked markers of hematopoietic cells, 
endothelial cells and fibroblasts. Mazzucchelli et al. (53) fur-
ther  extended  this  observation  by  detailed  morphological 
analysis and found that in the cortex, IL-7
＋ cells appear to 
envelop  thymocytes  in  a  “basket-like”  shape,  while  in  the 
m ed u lla ,  a n e x t en si ve  ne t wo rk  of  p ro ce ss es  ex t e nd e d fr om 
IL-7
＋ cells that made contact with thymocytes. Ontogenically, 
IL-7 reporter expression was first detectable in E12.5 fetal thy-
m u s e s  ( 6 0 )  a n d  f u l l y  e x p r e s s e d  t h r o u g h o u t  t h e  t h y m u s  a t  
E13.5  (57).  Interestingly,  IL-7
＋ T E C  f r e q u e n c y  s t e a d i l y  d e -
clined with increasing numbers of thymocytes and thymic ma-
turation, and was augmented when thymocyte development 
was  intrinsically  blocked,  suggesting  a  potential  negative 
feedback  of thymocytes  on IL-7
＋  TECs  (60).  Indeed, IL-7
＋ 
TEC frequencies were significantly increased in immunocom-
promised  mice  such  as  in  Rag2
−/−Il2rg
−/−  mice  whereas 
bone marrow transfer of either Tcra
−/− or WT cells markedly 
reduced  their  frequencies.  These  data  suggest  that  thymo-
cyte-derived signals modulate IL-7 expression by remodeling 
the  thymic  stroma,  and  it  uncovers  a  novel  thymocyte-TEC 
cross-talk  mechanism  in  the  development  of  T  cells  (60).
    Outside of the thymus, identification of IL-7 reporter pos-
itive cells remains somewhat controversial. All reporter mice 
using fluorescent proteins to monitor IL-7 expression fail to 
detect IL-7 expression in any other peripheral organ than the 
bone marrow (51,53). Moreover, even mice in which IL-7 ex-
p r e s s i o n  w a s  m a p p e d  b y  C r e  o r  l u c i f e r a s e  a c t i v i t y  d i d  n o t  
completely agree on the tissue distribution of IL-7 producer 
cells (52,54). Nevertheless, it seems that every study agrees 
that  IL-7  expression  was  below  detectable  levels  in  spleen 
and kidney, while the skin and intestine showed strong sig-
nals of IL-7 reporter expression. Investigating the role of IL-7 
in these organs will be clearly the subject of future studies.
    However,  harnessing  the  power  of  newly  generated  IL-7 
reporter  mice,  a  series  of  questions  have  been  already 
addressed. As mentioned above, thymic IL-7 expression was 
developmentally regulated and not fixed. In fact, frequency 
of  IL-7
＋  TECs  declined  with  age,  and  there  was  a  marked 
reduction of IL-7
＋ cell frequency in 5∼7 weeks aged mice 
compared  to  neonatal  and  1∼2  weeks  old  mice  (51). 
Furthermore, in addition to IL-7, the thymic stromal lympho-
poietin (TSLP) also utilizes the IL-7Rα and STAT5 for signal-
ing in T cells, and TSLP has been proposed to be a partially 
redundant pro-survival cytokine in immature thymocytes (61). 
However, using IL-7 reporter mice, IL-7 and TSLP expression 
was now shown to occupy different cellular and anatomical 
niches  suggesting  that  IL-7  plays  a  distinct  role  to  TSLP  in 
thymopoiesis. Such analyses at single cell levels were difficult 
to  do  before  the  availability  of  IL-7  reporter  mice.
    Another interesting observation from IL-7 reporter mice is 
the reduced frequency of IL-7 expressing TECs by TCRβ-se-
lected thymocytes (60). This finding is in agreement with a 
previous study by Zamisch et al. (57). There, the authors ob-
served that introduction of a TCRβ transgene into RAG2-defi-
cient mice largely restored thymic cellularity and also the gen-Detecting In Vivo Interleukin-7
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eration of DP thymocytes but that it paradoxically resulted in 
diminished frequencies of IL-7
＋ TECs. Similarly, IL-7
＋ TECs 
are retained in the thymus of mice with profound and early 
block in thymocyte development (Rag2
−/−Il2rg
−/−) and re-
constitution of alymphoid reporter thymus with Tcra
−/− hem-
atopoietic progenitors diminishes the frequency of IL-7
＋ TECs 
(60). Together, these data revealed that thymocytes negatively 
regulate  thymic  IL-7  production,  but  the  biological  sig-
nificance  of  this  feedback  mechanism  still  needs  to  be 
addressed.
    With the ability to visualize IL-7 producing cells, it is now 
possible to track their biological activities in vivo and in real 
time. A compelling study by Durum and colleagues (53) as-
sessed the interactions of T cells with ECFP
＋ IL-7 producing 
stromal cells using intravital microscopy. Central memory T 
cells  (TCM)  are  known  to  home  to  the  bone  marrow,  and 
it had been suggested that IL-7 signaling by bone marrow res-
ident stromal cells could be involved (62). Indeed, two pho-
ton  microscopy  of  CFSE-labeled  and  intravenously  injected 
TCMs displayed a preferential interaction with IL-7
＋ produc-
ing cells in the bone marrow, but subsequent studies showed 
that such preferential encounters was independent of IL-7 or 
the chemokine CXCL12 (53). Thus, while the exact identity 
of IL-7 producing cells in the bone marrow is unknown and 
also why TCM preferentially interact with these cells is un-
clear, these data confirm the power of IL-7-reporter mice in 
assessing  unresolved  questions  on  IL-7  biology  in  vivo.
    Finally, IL-7 expression was shown to be expressed by in-
testinal epithelial cells (IEC) in the gut (37). IL-7 reporter mice 
confirmed  this  observation  by  displaying  strong  biolumi-
nescence in the intestine and more specifically in EpCAM
＋ 
IECs. Since in vitro data suggested that IL-7 expression in IEC 
is regulated by IFN-γ (63), IL-7 reporter activity was assessed 
in Ifng
−/− mice and a significant reduction in IL-7 expression 
was found in the colon (54). Interestingly, intestinal IFN-γ 
expression  itself  was  dependent  on  an  intact  commensal 
microflora.  These  observations  suggest  a  novel  regulatory 
mechanism for mucosal IL-7 expression: IFN-γ expression is 
induced by the microflora in the gut, and IFN-γ directly up-
regulates IL-7 expression in IEC which then supports the sur-
vival of intestinal T cells. These findings provide a powerful 
clue in understanding the role of the commensal microbiota 
in the cytokine-mediated homeostasis of the mucosal immune 
system.
CONCLUSION
The availability of new IL-7 reporter mice provided new in-
formation on the in vivo expression and regulation of IL-7. 
These studies confirmed thymic stroma as a site of high IL-7 
expression  levels.  These  studies  also  enabled  the  identi-
fication  and  precise  phenotyping  of  IL-7  producing  cells  in 
the thymus as thymic epithelial cells whose development and 
maintenance  were  actively  regulated  during  ontogeny  and 
aging. In peripheral tissues, IL-7 producing cells were identi-
fied in a number of different tissues including lymph node, 
skin and intestine, but reporter activity also allowed the ex-
clusion  of  spleen  as  an  IL-7
＋ s i t e .  I m p o r t a n t l y ,  I L - 7  e x -
pression by IECs in the intestine was found to be dependent 
on the commensal microflora and regulated by IFN-γ, which 
suggest that IL-7 expression can be actively modulated and 
is locally controlled. The new information gained from these 
IL-7  reporter  mice  greatly  improved  our  understanding  on 
IL-7 function by illuminating the source of in vivo IL-7. We 
anticipate that these new tools  will provide us with further 
insights  in  future  studies.
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